APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Female STD Test Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Female STD Test Service Market Outlook and Growth Opportunities 2026

Report ID 17413941042 May 2026182 pages

Choose your research edition.

Industry ResearchFemale STD Test Service Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Female STD Test Service Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Female STD Test Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Female STD Test Service Market Outlook and Growth Opportunities 2026182 pages · $4,250 USDMarket Analysis & ForecastGlobal Female STD Test Service Market Analysis and Forecast 2026-2032259 pages · $4,950 USD

Market perspective

The global Female STD Test Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Female STD Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Female STD Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Female STD Test Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Female STD Test Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Female STD Test Service market include Everlywell, myLAB Box, LifeCell, Nurx, STD, Randox, Lets Get Checked, Lloyds Online Doctor and Yoxly, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Female STD Test Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Female STD Test Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Female STD Test Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Female STD Test Service market.

Female STD Test Service Segment by Company

Everlywell

myLAB Box

LifeCell

Nurx

STD

Randox

Lets Get Checked

Lloyds Online Doctor

Yoxly

Female STD Test Service Segment by Type

Blood Sample

Urine Sample

Others

Female STD Test Service Segment by Application

HIV Test

Hepatitis C Test

Syphilis Test

Chlamydia Test

Gonorrhea Test

Others

Female STD Test Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Female STD Test Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Female STD Test Service key companies, revenue, market share, and recent developments.

3. To split the Female STD Test Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Female STD Test Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Female STD Test Service significant trends, drivers, influence factors in global and regions.

6. To analyze Female STD Test Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female STD Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Female STD Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female STD Test Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Female STD Test Service industry.

Chapter 3: Detailed analysis of Female STD Test Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Female STD Test Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Female STD Test Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Female STD Test Service Industry Trends Table 2. Female STD Test Service Industry Drivers Table 3. Female STD Test Service Industry Opportunities and Challenges Table 4. Female STD Test Service Industry Restraints Table 5. Global Female STD Test Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Female STD Test Service Revenue Share by Company (2021-2026) Table 7. Global Female STD Test Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Female STD Test Service Key Company Manufacturing Base & Headquarters Table 9. Global Female STD Test Service Company, Product Type & Application Table 10. Global Female STD Test Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Female STD Test Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Blood Sample Table 15. Significant Companies of Urine Sample Table 16. Significant Companies of Others Table 17. Global Female STD Test Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Female STD Test Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Female STD Test Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Female STD Test Service Sales Value Share by Type (2021-2026) Table 21. Global Female STD Test Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of HIV Test Table 23. Significant Companies of Hepatitis C Test Table 24. Significant Companies of Syphilis Test Table 25. Significant Companies of Chlamydia Test Table 26. Significant Companies of Gonorrhea Test Table 27. Significant Companies of Others Table 28. Global Female STD Test Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Female STD Test Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Female STD Test Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Female STD Test Service Sales Value Share by Application (2021-2026) Table 32. Global Female STD Test Service Sales Value Share by Application (2027-2032) Table 33. Global Female STD Test Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Female STD Test Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Female STD Test Service Sales Value Share by Region (2021-2026) Table 36. Global Female STD Test Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Female STD Test Service Sales Value Share by Region (2027-2032) Table 38. Global Female STD Test Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Female STD Test Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Female STD Test Service Sales Value Market Share by Country (2021-2026) Table 41. Global Female STD Test Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Female STD Test Service Sales Value Market Share by Country (2027-2032) Table 43. Everlywell Company Information Table 44. Everlywell Business Overview Table 45. Everlywell Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Everlywell Female STD Test Service Product Portfolio Table 47. Everlywell Recent Development Table 48. myLAB Box Company Information Table 49. myLAB Box Business Overview Table 50. myLAB Box Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. myLAB Box Female STD Test Service Product Portfolio Table 52. myLAB Box Recent Development Table 53. LifeCell Company Information Table 54. LifeCell Business Overview Table 55. LifeCell Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. LifeCell Female STD Test Service Product Portfolio Table 57. LifeCell Recent Development Table 58. Nurx Company Information Table 59. Nurx Business Overview Table 60. Nurx Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Nurx Female STD Test Service Product Portfolio Table 62. Nurx Recent Development Table 63. STD Company Information Table 64. STD Business Overview Table 65. STD Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. STD Female STD Test Service Product Portfolio Table 67. STD Recent Development Table 68. Randox Company Information Table 69. Randox Business Overview Table 70. Randox Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Randox Female STD Test Service Product Portfolio Table 72. Randox Recent Development Table 73. Lets Get Checked Company Information Table 74. Lets Get Checked Business Overview Table 75. Lets Get Checked Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Lets Get Checked Female STD Test Service Product Portfolio Table 77. Lets Get Checked Recent Development Table 78. Lloyds Online Doctor Company Information Table 79. Lloyds Online Doctor Business Overview Table 80. Lloyds Online Doctor Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lloyds Online Doctor Female STD Test Service Product Portfolio Table 82. Lloyds Online Doctor Recent Development Table 83. Yoxly Company Information Table 84. Yoxly Business Overview Table 85. Yoxly Female STD Test Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Yoxly Female STD Test Service Product Portfolio Table 87. Yoxly Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Female STD Test Service Product Image Figure 2. Global Female STD Test Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Female STD Test Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Female STD Test Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Blood Sample Image Figure 8. Urine Sample Image Figure 9. Others Image Figure 10. Global Female STD Test Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Female STD Test Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Female STD Test Service Sales Value Share by Type (2021-2032) Figure 13. HIV Test Image Figure 14. Hepatitis C Test Image Figure 15. Syphilis Test Image Figure 16. Chlamydia Test Image Figure 17. Gonorrhea Test Image Figure 18. Others Image Figure 19. Global Female STD Test Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Female STD Test Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Female STD Test Service Sales Value Share by Application (2021-2032) Figure 22. Global Female STD Test Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Female STD Test Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Female STD Test Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Female STD Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Female STD Test Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Female STD Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Female STD Test Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Female STD Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Female STD Test Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Female STD Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Female STD Test Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Female STD Test Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Female STD Test Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Female STD Test Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Female STD Test Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Sample
  • Urine Sample
  • Others
Applications
  • HIV Test
  • Hepatitis C Test
  • Syphilis Test
  • Chlamydia Test
  • Gonorrhea Test
  • Others
Companies covered
  • Everlywell
  • myLAB Box
  • LifeCell
  • Nurx
  • STD
  • Randox
  • Lets Get Checked
  • Lloyds Online Doctor
  • Yoxly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Female STD Test Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Female STD Test Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Female STD Test Service Market Dynamics
  1. 2.1 Female STD Test Service Industry Trends
  2. 2.2 Female STD Test Service Industry Drivers
  3. 2.3 Female STD Test Service Industry Opportunities and Challenges
  4. 2.4 Female STD Test Service Industry Restraints
3 Female STD Test Service Market by Company
  1. 3.1 Global Female STD Test Service Company Revenue Ranking in 2025
  2. 3.2 Global Female STD Test Service Revenue by Company (2021-2026)
  3. 3.3 Global Female STD Test Service Company Ranking (2024-2026)
  4. 3.4 Global Female STD Test Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Female STD Test Service Company Product Type and Application
  6. 3.6 Global Female STD Test Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Female STD Test Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Female STD Test Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Female STD Test Service Market by Type
  1. 4.1 Female STD Test Service Type Introduction
  2. 4.1.1 Blood Sample
  3. 4.1.2 Urine Sample
  4. 4.1.3 Others
  5. 4.2 Global Female STD Test Service Sales Value by Type
  6. 4.2.1 Global Female STD Test Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Female STD Test Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Female STD Test Service Sales Value Share by Type (2021-2032)
5 Female STD Test Service Market by Application
  1. 5.1 Female STD Test Service Application Introduction
  2. 5.1.1 HIV Test
  3. 5.1.2 Hepatitis C Test
  4. 5.1.3 Syphilis Test
  5. 5.1.4 Chlamydia Test
  6. 5.1.5 Gonorrhea Test
  7. 5.1.6 Others
  8. 5.2 Global Female STD Test Service Sales Value by Application
  9. 5.2.1 Global Female STD Test Service Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Female STD Test Service Sales Value by Application (2021-2032)
  11. 5.2.3 Global Female STD Test Service Sales Value Share by Application (2021-2032)
6 Female STD Test Service Regional Value Analysis
  1. 6.1 Global Female STD Test Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Female STD Test Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Female STD Test Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Female STD Test Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Female STD Test Service Sales Value (2021-2032)
  7. 6.3.2 North America Female STD Test Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Female STD Test Service Sales Value (2021-2032)
  10. 6.4.2 Europe Female STD Test Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Female STD Test Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Female STD Test Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Female STD Test Service Sales Value (2021-2032)
  16. 6.6.2 South America Female STD Test Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Female STD Test Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Female STD Test Service Sales Value Share by Country, 2025 VS 2032
7 Female STD Test Service Country-level Value Analysis
  1. 7.1 Global Female STD Test Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Female STD Test Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Female STD Test Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Female STD Test Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Female STD Test Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Female STD Test Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Female STD Test Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Female STD Test Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Female STD Test Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Female STD Test Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Female STD Test Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Female STD Test Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Female STD Test Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Female STD Test Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Female STD Test Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Female STD Test Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Female STD Test Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Female STD Test Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Female STD Test Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Female STD Test Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Female STD Test Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Female STD Test Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Female STD Test Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Female STD Test Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Female STD Test Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Female STD Test Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Female STD Test Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Female STD Test Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Female STD Test Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Female STD Test Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Female STD Test Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Female STD Test Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Female STD Test Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Female STD Test Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Female STD Test Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Everlywell
  2. 8.1.1 Everlywell Company Information
  3. 8.1.2 Everlywell Business Overview
  4. 8.1.3 Everlywell Female STD Test Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Everlywell Female STD Test Service Product Portfolio
  6. 8.1.5 Everlywell Recent Developments
  7. 8.2 myLAB Box
  8. 8.2.1 myLAB Box Company Information
  9. 8.2.2 myLAB Box Business Overview
  10. 8.2.3 myLAB Box Female STD Test Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 myLAB Box Female STD Test Service Product Portfolio
  12. 8.2.5 myLAB Box Recent Developments
  13. 8.3 LifeCell
  14. 8.3.1 LifeCell Company Information
  15. 8.3.2 LifeCell Business Overview
  16. 8.3.3 LifeCell Female STD Test Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LifeCell Female STD Test Service Product Portfolio
  18. 8.3.5 LifeCell Recent Developments
  19. 8.4 Nurx
  20. 8.4.1 Nurx Company Information
  21. 8.4.2 Nurx Business Overview
  22. 8.4.3 Nurx Female STD Test Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nurx Female STD Test Service Product Portfolio
  24. 8.4.5 Nurx Recent Developments
  25. 8.5 STD
  26. 8.5.1 STD Company Information
  27. 8.5.2 STD Business Overview
  28. 8.5.3 STD Female STD Test Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 STD Female STD Test Service Product Portfolio
  30. 8.5.5 STD Recent Developments
  31. 8.6 Randox
  32. 8.6.1 Randox Company Information
  33. 8.6.2 Randox Business Overview
  34. 8.6.3 Randox Female STD Test Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Randox Female STD Test Service Product Portfolio
  36. 8.6.5 Randox Recent Developments
  37. 8.7 Lets Get Checked
  38. 8.7.1 Lets Get Checked Company Information
  39. 8.7.2 Lets Get Checked Business Overview
  40. 8.7.3 Lets Get Checked Female STD Test Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lets Get Checked Female STD Test Service Product Portfolio
  42. 8.7.5 Lets Get Checked Recent Developments
  43. 8.8 Lloyds Online Doctor
  44. 8.8.1 Lloyds Online Doctor Company Information
  45. 8.8.2 Lloyds Online Doctor Business Overview
  46. 8.8.3 Lloyds Online Doctor Female STD Test Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lloyds Online Doctor Female STD Test Service Product Portfolio
  48. 8.8.5 Lloyds Online Doctor Recent Developments
  49. 8.9 Yoxly
  50. 8.9.1 Yoxly Company Information
  51. 8.9.2 Yoxly Business Overview
  52. 8.9.3 Yoxly Female STD Test Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Yoxly Female STD Test Service Product Portfolio
  54. 8.9.5 Yoxly Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst